Trial Profile
A phase 3 study of XP23829 in patients with chronic plaque-type psoriasis
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 22 Aug 2017
Price :
$35
*
At a glance
- Drugs Tepilamide-fumarate (Primary)
- Indications Plaque psoriasis
- Focus Registrational; Therapeutic Use
- Sponsors Dr Reddys Laboratories
- 17 Sep 2015 New trial record
- 15 Sep 2015 According to XenoPort media release, company expects to start this trial by 2016.